Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -973 | N/A | N/A |
| Depreciation Amortization | 1 | N/A | N/A |
| Accounts receivable | -36 | N/A | N/A |
| Other Working Capital | 182 | N/A | N/A |
| Other Operating Activity | 36 | 0 | 0 |
| Operating Cash Flow | $-790 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -7 | N/A | N/A |
| Investing Cash Flow | $-7 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 1,050 | N/A | N/A |
| Financing Cash Flow | $1,050 | $N/A | $N/A |
| Exchange Rate Effect | 19 | N/A | N/A |
| Beginning Cash Position | 462 | N/A | N/A |
| End Cash Position | 734 | N/A | N/A |
| Net Cash Flow | $272 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -790 | N/A | N/A |
| Capital Expenditure | -7 | N/A | N/A |
| Free Cash Flow | -797 | 0 | 0 |